PATENT CLAIM ANALYSIS

Application Number: 15862310
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["702", "019000"]

Abstract:
A method of administering insulin includes receiving blood glucose measurements of a patient at a data processing device from a glucometer. Each blood glucose measurement is separated by a time interval and includes a blood glucose time associated with a time of measuring the blood glucose measurement. The method also includes receiving patient information at the data processing device and selecting a subcutaneous insulin treatment for tube-fed patients from a collection of subcutaneous insulin treatments. The selection is based on the blood glucose measurements and the patient information. The subcutaneous insulin treatment program for tube-fed patients determines recommended insulin doses based on the blood glucose times. The method also includes executing, using the data processing device, the selected subcutaneous insulin treatment.

Claim (Index 18):
The system of  claim 16 , wherein the operations further comprise:\n determining for a given blood glucose time within a first sequential time interval of the four sequential time intervals or a second sequential time interval of the six sequential time intervals, a given blood glucose measurement that is within one of a plurality of target ranges of values; determining an adjustment factor for adjusting a value of recommended equal-boluses to the patient based on the corresponding target range of values and the given blood glucose measurement; retrieving a previous day's value of recommended equal-boluses; determining a new value of recommended equal-boluses by multiplying the adjustment factor times the previous day's value of recommended equal-boluses; and administering the new value of recommended equal-boluses to the patient by transmitting the new value of recommended equal-boluses from the data processing device to the dose administering system having the patient display at the sequential time intervals, the patient display configured to display a third number of units of insulin corresponding to the new value of recommended equal-boluses and trigger administration of the third number of units of insulin to the patient at each of the sequential time intervals.

Metadata:
- Claim Count in Document: 45.0
- Percentile: 86.0
- Lexical Diversity: 2.38889
- Patent Class: 702.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14524756', '14524918', '14938997', '15342606', '14922763']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.4119786387514311
- 35 USC 102 Novelty (BERT): 0.6606044796370558
- Combined Prediction Score: 0.4368412228399935
- Mean Citation Score: 659.7472399999998
- Max Citation Score: 718.5857
- Similarity Product: 628.5277305402219

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test